Thus, here, we decided first to evaluate macrophage activation in MAFLD/NASH, then to characterize fetuin-A in the serum, the liver, and the AT during progression along the MAFLD spectrum and, finally, to investigate the possible interactions between fetuin-A and liver macrophages in this context. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatohepatitis.